Akebia Therapeutics Inc (AKBA)
EBITDA Margin
-10.55%
Quarterly · Period ending:
AKBA EBITDA Margin
Latest reported-10.55%period ending
Latest reported-10.55%period ending
AKBA Quarterly EBITDA Margin (0.00% → -10.55%)
Quarterly ebitda margin
High-resolution chart · PNG
AKBA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -10.548% | |
| -24.8226% | |
| -10.564% | |
| 10.5861% | |
| 11.8405% | |
| 24.7593% | |
| -14.1558% | |
| -10.6979% | |
| 2.7149% | |
| -15.0673% | |
| 20.3502% | |
| -8.7333% | |
| -0.2182% | |
| -39.76% | |
| 31.1635% | |
| -83.5899% | |
| 34.7501% | |
| -77.6852% | |
| -83.1579% | |
| -92.2451% | |
| -129.5844% | |
| -105.6344% | |
| -83.7704% | |
| -85.1254% | |
| -181.7377% | |
| -55.5505% | |
| -93.769% | |
| -50.1875% | |
| -48.9222% | |
| -90.3297% | |
| -144.8204% | |
| -51.9438% | |
| -72.6498% | |
| -52.9044% | |
| 13.2438% | |
| -58.1571% | |
| -77.202% | |
| -214.891% | |
| -2,470.3583% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |